Abbott Laboratories Stock
Abbott Laboratories
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Robert Ford
- Employees
- 115,000
- Market cap
- $181.5 B
- IPO
- 17/03/1980
Abbott Laboratories is a global healthcare enterprise headquartered in Abbott Park. Founded in 1888, the company focuses on the research, development, manufacturing, and worldwide distribution of diverse health solutions. The business operates through four primary divisions: Established Pharmaceutical Products,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Abbott Laboratories stock: price history
1D
+0.2%
1W
+5.3%
1M
+2.5%
6M
+8.3%
YTD
-16.3%
1Y
-17.8%
2Y
-11.0%
5Y
-10.7%
10Y
+154.8%
Next earnings date
Next earnings date
21/10/2026 (in 4 days)
Volatility around earnings
~72% stronger price swings than usual
Abbott Laboratories stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Abbott Laboratories
Analyst assessment of Abbott Laboratories
PRICE TARGET LOW
US$92.00
CONSENSUS
US$119.92
MEDIAN
US$120.00
PRICE TARGET HIGH
US$134.00
0
STRONG BUY
33
BUY
9
HOLD
0
SELL
0
STRONG SELL
42
TOTAL · Buy
As of: 02/10/2026
Abbott Laboratories stock metrics
P/E
33.72
P/B
3.58
EV/EBITDA
18.45
RETURN ON EQUITY
1.8%
NET MARGIN
7.4%
DEBT/EQUITY
0.64
DIVIDEND YIELD
2.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.4%
FLOAT SHARES
1,719,845,262
AVG. DAILY VOLUME (30D)
9,159,585
Insider transactions (SEC)
Conroy Kevin T
MCCOY JOHN A. JR.
Boudreau Philip P
MCCOY JOHN A. JR.
Ford Robert B
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.2%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Abbott Laboratories stock
What does Abbott Laboratories do?
Abbott Laboratories is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Robert Ford, the company employs around 115,000 people.
The IPO was on 17/03/1980; the stock trades on NYSE under the ticker ABT.
What do analysts say about Abbott Laboratories stock?
42 analysts rate the stock, the consensus is Buy (as of 02/10/2026).
The average price target is US$119.92, ranging from US$92.00 to US$134.00, with a median of US$120.00.
This is an external assessment, not a statement by Market Jury.
When does Abbott Laboratories report next?
The next earnings date is 21/10/2026.
Around past earnings, price swings were roughly 72% stronger than usual.
Does Abbott Laboratories pay a dividend?
Yes. The last dividend was US$0.63 per share, ex-date 15/10/2026, paid on 16/11/2026.
The dividend yield is 2.4% (as of 30/06/2026).
Which stocks are comparable to Abbott Laboratories?
Comparable stocks include Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings, Align Technology and Bio-Rad Laboratories.
How can I get Abbott Laboratories stock analyzed?
Clicking "Analyze stock" lets five strategies assess Abbott Laboratories against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.